Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical …

A Shariati, M Dadashi, MT Moghadam, A van Belkum… - Scientific reports, 2020 - nature.com
Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …

Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates

Q Wu, N Sabokroo, Y Wang, M Hashemian… - … Resistance & Infection …, 2021 - Springer
Abstract Background Vancomycin‑resistant Staphylococcus aureus (VRSA) is a serious
public health challenging concern worldwide. Objectives Therefore, the objective of present …

Antimicrobial Treatment of Staphylococcus aureus Biofilms

FF Tuon, PH Suss, JP Telles, LR Dantas, NH Borges… - Antibiotics, 2023 - mdpi.com
Staphylococcus aureus is a microorganism frequently associated with implant-related
infections, owing to its ability to produce biofilms. These infections are difficult to treat …

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci …

A Shariati, M Dadashi, Z Chegini, A van Belkum… - … Resistance & Infection …, 2020 - Springer
Abstract Objective Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-
resistant coagulase-negative Staphylococcus (MRCoNS) are among the main causes of …

Methicillin-resistant Staphylococcus aureus in food and the prevalence in Brazil: a review

AC da Silva, MX Rodrigues, NCC Silva - Brazilian Journal of Microbiology, 2020 - Springer
Foodborne diseases (FBD) occur worldwide and affect a large part of the population, being
a cause of international concern among health authorities. Staphylococcus aureus can be …

Molecular Characterization of Community- and Hospital- Acquired Methicillin-Resistant Staphylococcus aureus Isolates during COVID-19 Pandemic

M Sohail, M Muzzammil, M Ahmad, S Rehman… - Antibiotics, 2023 - mdpi.com
Methicillin-resistant Staphylococcus aureus (MRSA) is a drug-resistant superbug that
causes various types of community-and hospital-acquired infectious diseases. The current …

Prevalence of tigecycline resistance in methicillin-resistant Staphylococcus aureus: a systematic review and meta-analysis

M Heidary, M Sholeh, A Asadi, SM Khah… - … and Infectious Disease, 2024 - Elsevier
Tigecycline (TG) is one of the newest antimicrobial drugs used in the treatment of methicillin-
resistant Staphylococcus aureus (MRSA) infections. The TG Resistance Evaluation and …

Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia

M Ejaz, MA Syed, CR Jackson, M Sharif, R Faryal - Antibiotics, 2023 - mdpi.com
Staphylococcus aureus is one of the ESKAPE (Enterococcus faecium, Staphylococcus
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and …

Determination of Virulence Factors and Resistance Profile of Methicillin‐Resistant Staphylococcus aureus Strains among Different Types of spa, agr, and SCCmec

M Latifpour, T Narimani, A Sadeghi… - BioMed Research …, 2022 - Wiley Online Library
In order to restrict the spread of methicillin‐resistant S. aureus (MRSA) in hospitals, it is
necessary to characterize isolates rapidly and precisely. The objective of this study was to …

Methicillin‐resistant Staphylococcus aureus contamination of high‐touched surfaces in a university campus

Q Ababneh, Z Jaradat, M Khanfar… - Journal of Applied …, 2022 - academic.oup.com
Abstract Aim Methicillin‐resistant Staphylococcus (MRSA) is a public and occupational
health concern, both in community and healthcare settings. In recent years, community …